NCT05025189

Brief Summary

This pilot study will assess the ability of daily consumption of one dose (2 servings) of freeze-dried whole table grape powder, made from conventionally grown grapes to alter the composition of the bacteria that live in the intestines in healthy subjects. The grape powder contains 46g of individually quick frozen (IQF) grapes, which is equivalent to 252g fresh fruit. 20 subjects will will consume the beige diet for 4 weeks followed by one dose (two servings) of standardized Freeze-Dried Whole Table Grape Powder (46g) daily for 4 weeks. The primary objective of this pilot study is to determine changes in the gut microbiome. Stool samples will be collected at 4 and 8 weeks for bacterial DNA to determine changes in the bacteria that live in the intestines. You will be asked to avoid foods rich in polyphenols including dark chocolate and cocoa products, dried herbs, berries, coffee, tea, flaxseeds, nuts (chestnut, hazelnut), olive and artichoke for the duration of the study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at P25-P50 for not_applicable healthy

Timeline
Completed

Started Oct 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 5, 2020

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 6, 2021

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2021

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

August 24, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 27, 2021

Completed
Last Updated

May 6, 2023

Status Verified

May 1, 2023

Enrollment Period

5 months

First QC Date

August 24, 2021

Last Update Submit

May 4, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in intestinal microbiome composition

    Stool samples will be collected at week 4 and 8 of the intervention periods

    Baseline (week 0) to Week 8

Secondary Outcomes (4)

  • change in fecal cholesterol, cholesterol metabolites, and bile acids

    Baseline (week 0) to Week 8

  • change in blood total cholesterol, LDL and HDL-cholesterol,

    Baseline (week 0) to Week 8

  • digestive Health and General Wellness questionnaires (Rand SF-36)

    Baseline (week 0) to Week 8

  • urine content of syringic acid, and ellagic acid metabolites - ellagic acid, and dimethylellagic acid glucuronide

    Baseline (week 0) to Week 8

Study Arms (2)

Table Grape

ACTIVE COMPARATOR

Subjects will consume 4 weeks of (two servings) of standardized Freeze-Dried Whole Table Grape Powder

Other: Table Grape Powder

Beige Diet

PLACEBO COMPARATOR

Subjects will consume 4 weeks of a beige diet (low in fiber and low in polyphenols)

Other: Beige Diet

Interventions

Freeze Dried Whole Table Grape Powder

Table Grape

Low Fiber, low polyphenol Diet

Beige Diet

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy human adults age 18-55 years old (females have to be premenopausal)
  • Typically consume low fiber/polyphenol diet (beige diet)

You may not qualify if:

  • Eating a high fiber/polyphenol diet or taking any medication or dietary supplement, which interfere with the absorption of polyphenols.
  • History of gastrointestinal surgery, diabetes mellitus on medications, or other serious medical condition, such as chronic hepatic or renal disease, bleeding disorder, congestive heart disease, chronic diarrhea disorders, myocardial infarction, coronary artery bypass graft, angioplasty within 6 months prior to screening, current diagnosis of uncontrolled hypertension (defined as systolic BP \>160mmHg, diastolic BP \> 95mmHg), active or chronic gastrointestinal disorders, bulimia, anorexia, laxative abuse, or endocrine diseases (except thyroid disease requiring medication) as indicated by medical history or routine physical examination.
  • Screening laboratory value outside of the laboratory normal range that is considered clinically significant for study participation by the investigator.
  • Is unable or unwilling to comply with the study protocol.
  • Using prebiotics, probiotics, yogurt, and/or any fiber supplements regularly
  • Allergy or sensitivity to grapes. Subjects will be excluded if there is a prior history of such sensitivity. Since these foods are commonly eaten and allergies are rare, subjects should be aware of this sensitivity prior to entering the study. To determine this, a positive affirmation by the subject of grape ingestion without incident will be requested.
  • Taking antibiotics or laxatives within the past 3 months
  • Allergy or sensitivity to grapes. Subjects will be excluded if there is a prior history of such sensitivity. Since these foods are commonly eaten and allergies are rare, subjects should be aware of this sensitivity prior to entering the study. To determine this, a positive history of grape ingestion without incident will be requested. In addition, any subject with a history of allergy or anaphylaxis of any kind will be excluded
  • Subjects with known allergy to food coloring dyes.
  • In the opinion of the study investigator, any subject who demonstrate a risk of non-compliance with study procedure, or one who cannot read, understand or complete study - related materials.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCLA Center for Human Nutrition

Los Angeles, California, 90024, United States

Location

Study Officials

  • Zhaoping Li, MD, PhD

    UCLA Center for Human Nutrition

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: This will be a two phase intervention study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief, Division of Clinical Nutrition

Study Record Dates

First Submitted

August 24, 2021

First Posted

August 27, 2021

Study Start

October 5, 2020

Primary Completion

March 6, 2021

Study Completion

July 30, 2021

Last Updated

May 6, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations